|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Short-term investments (note 5) | |||||||||||||||||
| Short-term marketable securities | |||||||||||||||||
| Accounts receivable | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Deferred financing fees | |||||||||||||||||
| Long-term investments (note 5) | |||||||||||||||||
| Long-term prepaid assets | |||||||||||||||||
| Long-term marketable securities | |||||||||||||||||
| Long-term prepaids and other assets | |||||||||||||||||
| Deferred tax asset | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||
| Acquired in-process research and development (note 6) | |||||||||||||||||
| Acquired in-process research and development assets (“IPR&D”) (note 6) | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Acquired intangible assets | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities and stockholders’ equity | |||||||||||||||||
| Current liabilities: | |||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||
| Income tax payable | |||||||||||||||||
| Fair value of liability-classified stock options | |||||||||||||||||
| Current portion of operating lease liability | |||||||||||||||||
| Contract with Customer, Liability, Current | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Long-term portion of operating lease liability | |||||||||||||||||
| Deferred revenue | |||||||||||||||||
| Liability related to the sale of future revenue | |||||||||||||||||
| Other long-term liabilities | |||||||||||||||||
| Unrecognized tax benefits | |||||||||||||||||
| Deferred tax liability | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||
| Common stock, $0.00001 par value; 900,000,000 authorized shares at September 30, 2026 and December 31, 2025; 71,176,875 and 74,638,413 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||
| Preferred shares, $0.00001 par value; 100,000,000 authorized shares of preferred stock, out of which, one share of preferred stock is a share of Special Voting Preferred Stock and outstanding as of September 30, 2026 and December 31, 2025 | |||||||||||||||||
| Exchangeable shares, no par value, 538,890 and 553,184 issued and outstanding shares at September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||
Loading...